27 June 2021>: Clinical Research
Analysis of Bone Strength and Bone Turnover Markers in Ankylosing Spondylitis with Radiological Hip Involvement
Wei Liu 1ABCDEFG , Hui Song 1ACDEFG* , Siliang Man 1BCD , Hongchao Li 1BDE , Liang Zhang 2BDDOI: 10.12659/MSM.932992
Med Sci Monit 2021; 27:e932992
Table 1 Information for AS with and without radiographic hip involvement.
RHI-AS (n=177) | WORHI-AS (n=162) | P | |
---|---|---|---|
Male, n (%) | 154 (87.0) | 129 (76.9) | 0.068 |
Age (years), median (Q1, Q3) | 27 (23, 37) | 37 (28, 48) | |
Course of disease (years), median (Q1, Q3) | 9 (5, 14) | 9 (4, 16) | 0.785 |
BMI (kg/m), mean±SD | 21.0 (18.7, 24.5) | 23.5 (21.2, 26.8) | |
Family history, n (%) | 21 (11.9) | 31 (19.1) | 0.063 |
Smoking history, n (%) | 97 (54.8) | 72 (44.4) | 0.057 |
HLA-B27 (positive), n (%) | 167 (94.4) | 147 (90.7) | 0.204 |
CRP (mg/dl), median (Q1, Q3) | 26 (12.1, 54.3) | 20.6 (9.8, 57.8) | 0.284 |
BASDAI, median (Q1, Q3) | 3.8 (2.4, 5.3) | 3.8 (2.2, 5.2) | 0.893 |
mSASSS, median (Q1, Q3) | 25 (14.5, 35) | 23 (14.8, 33.5) | 0.821 |
RHI-AS – ankylosing spondylitis with radiographic hip involvement; WORHI-AS – ankylosing spondylitis without radiographic hip involvement. |